Transforming growth factor β1 and its latent form binding protein-1 associate with elastic fibres in human dermis: Accumulation in actinic damage and absence in anetoderma

British Journal of Dermatology

Volumn 137, Issue 1, 1997, Pages 51-58

  Karonen, T ^a   Jeskanen, L ^a   Keski Oja, J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; ELASTASE; ELASTIN; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TRYPSIN;

ACTINIC KERATOSIS; ADOLESCENT; ADULT; AGED; ANETODERMA; ARTICLE; CHILD; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMIS; ELASTIC FIBER; ELASTOSIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOXANTHOMA ELASTICUM;

EID: 0030786999     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03700.x     Document Type: Article

References (34)

1. Wahl SM. Transforming growth factor beta (TGF-β in inflammation: a cause and a cure. J Clin Immunol 1992; 12: 61-73.
2. Taipale J. Miyazono K, Heldin C-H, Keski-Oja J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 1994; 124: 171-81.
3. Olofsson A, Miyazono K, Kanzaki T et al. Transforming growth factor-β1. -β2. and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 1992; 267: 19482-8.
4. Miyazono K, Hellman U, Wernstedt C, Heldin C-H. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol chem 1988; 263: 6407-15.
5. Miyazono K, Olofsson A, Colosetti P, Heldin C-H. A role of the latent TGF-β 1-binding protein in the assembly and secretion of TGF-β1. EMBO J 1991; 10: 1091-101.
6. Taipale J, Lohi J, Saarinen J et al. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995; 270: 4689-96.
7. Taipale J, Saharinen J, Hedman K, Keski-Oja J. Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 1996; 44: 1-15.
8. Kanzaki T, Olofsson A, Moren A et al. TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 1990; 61: 1051-61.
9. Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: The elastic fiber. FASEB J 1993; 7: 1208-18.
10. Zhang H, Apfelroth SD, Hu W et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994; 124: 855-63.
11. Mizoi T, Ohtani H, Miyazono K et al. Immunoelectron microscopic localization of transforming growth factor-β1 and latent transforming growth factor-β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993; 53: 183-90.
12. Dallas SL, Miyazono K, Skerry TM et al. Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol 1995; 131: 539-49.
13. Taipale J, Koli K, Keski-Oja J. Release of transfoming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992; 267: 25378-84.
14. Lyons RM, Gentry LE, Purchio AF, Moses HL, Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 1990; 110: 1361-7.
15. Sato Y, Tsuboi R, Lyons R et al. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 1990; 111: 757-63.
16. Sato Y, Okada F, Abe M et al. The mechanism of the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: Cell-type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol 1993; 123: 1249-54.
17. Lopez-Casillas F, Payne HM, Andres JL, Massague J. Betaglycan can act as a dual modulator of TGF-β access to signalling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 1994; 124: 557-68.
18. Lamarre J, Vasudevan J, Gonias SL. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-β complex from the cell surface. Biochem J 1994; 302: 199-205.
19. Laiho M, Weis MB, Massague J. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 1990; 265: 18518-24.
20. Laiho M, Weis FM, Boyd FT et al. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem 1991; 266: 9108-12.
21. Wrana JL, Attisano L, Carcamo J et al. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992; 71: 1003-14.
22. Wrana JL, Tran H, Attisano L et al. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form activin receptor complex. Mol Cell Biol 1994; 14: 944-50.
23. Lever WF, Schaumberg-Lever G. Histopathology of the Skin. 7th edn. Philadelphia: JB Lippincott, 1990; 84-86. 298-300. 313, 542-6.
24. Braverman IM, Forfenko E, Studies in cutaneous aging: I. The elastic fiber network. J Invest Dermatol 1982; 78: 434-43.
25. Chen VL, Fleischmajer R, Schwartz E et al. Immunohistochemistry of elastotic material in sun-damaged skin. J Invent Dermatol 1986; 87: 334-7.
26. Bernstein EF, Chen YQ, Tamai K et al. Enhanced elastin and fibrillin gene expression in chronically photodamaged skin. J Invest Dermatol 1994; 103: 182-6.
27. Lavker RM, Kligman AM. Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1988; 90: 325-30.
28. Edwards DR, Murphy G, Reynolds JJ et al. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase Inhibitor. EMBO J 1987; 6: 1899-904.
29. Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-β alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res 1986; 164: 399-407.
30. Gailit J, Welch MP, Clark RAF. TGF-β1 stimulates expression of keratinocyte integrins during re-epithelization of cutaneous wounds. J Invest Dermatol 1994; 103: 221-7.
31. Quaglino D Jr, Nanney LB, Ditesheim JA et al. Transforming growth factor-β stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Dermatol 1991: 97: 34-42.
32. Schmid P. Cox D, Bilbe G et al. TGF-βs and TGF-β type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 1995; 171: 191-7.
33. Schmid P, Kunz S, Cerletti N et al. Injury induced expression of TGF-β1 mRNA is enhanced by exogenously applied TGF-β S. Biochem Biophys Res Commun 1991; 194: 399-406.
34. Schmid P, Itin P, Rufli TH. In situ analysis of transforming growth factors-β (TGF-β1. TGF-β2. TGF-β3) and TGF-β type II receptor expression in basal cell carcinomas. Br J Dermatol 1996; 134: 1044-51.